ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AZN Astrazeneca Plc

10,724.00
-18.00 (-0.17%)
Last Updated: 08:46:13
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -18.00 -0.17% 10,724.00 10,724.00 10,728.00 10,780.00 10,722.00 10,756.00 110,974 08:46:13
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 45.81B 5.96B 3.8415 28.04 166.99B

Brazil Authorizes Use of Two Covid-19 Vaccines -- Update

17/01/2021 7:06pm

Dow Jones News


Astrazeneca (LSE:AZN)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Astrazeneca Charts.
By Samantha Pearson and Luciana Magalhaes 

Brazilian health regulator Anvisa voted Sunday to approve the use of the country's first Covid-19 vaccines, China's CoronaVac and the shot developed by AstraZeneca PLC and Oxford University, raising spirits in a nation that is struggling to cope with a surge in infections.

The ruling follows a tug of war between President Jair Bolsonaro and São Paulo's powerful state governor, João Doria, to secure the first vaccines for the country of more than 210 million people.

Gov. Doria, who is expected to run for president next year, has led a partnership with Chinese company Sinovac Biotech Ltd. to test and produce CoronaVac in São Paulo, criticizing what he has called a "genocidal" lack of action by Mr. Bolsonaro.

The dispute comes as the country's average daily death toll approaches 1,000 people, with scientists warning that a new variant that likely emerged in the Amazon could be partly responsible for a recent surge in infections. For the past week, Brazil has registered an average of more than 50,000 new cases of the disease each day -- the highest since the pandemic began.

Write to Samantha Pearson at samantha.pearson@wsj.com and Luciana Magalhaes at Luciana.Magalhaes@wsj.com

 

(END) Dow Jones Newswires

January 17, 2021 13:51 ET (18:51 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

1 Year Astrazeneca Chart

1 Year Astrazeneca Chart

1 Month Astrazeneca Chart

1 Month Astrazeneca Chart

Your Recent History

Delayed Upgrade Clock